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CHAPTER I 
REVIEW OF THE LITERATURE 
Cellular uptake of proteins by endocytosis serves many 
specialized functions. Examples are the transference of 
immunity from mother to child (1), regulation of cholesterol 
metabolism (2), the cell acquisition of essential nutrients 
(3), the regulation of hormonal receptors at the cell surface 
(4), and the hydrolysis of proteins to their constituent amino 
acids contributing to overall homeostasis of proteins in the 
circulation (3). 
Proteins from the extracellular environment can gain 
access to the cell interior by either of two ways. The first 
is constitutive fluid phase pinocytosis (5) and involves the 
formation of small (0.1-0.2um) vesicles (6). In pinocytosis 
the vesicles invaginate from the plasma membrane and engulf 
the solute. The process occurs at a constant rate 
characteristic for a given cell type. The rate of uptake of 
horseradish peroxidase by fluid phase pinocytosis can be 
linear for up to days in culture (7,8). Pinocytosis is only 
partially inhibited by agents which disrupt microfilaments or 
microtubules (5), and is stopped by temperatures below 10°c 
1 
( 9) • 
Considerable amounts of plasma membrane are internalized 
by pinocytosis. The sterologic measurements of HRP uptake by 
macrophages and fibroblasts indicate that up to 200% and 50% 
respectively of the entire cell surface area is internalized 
per hour (10). Large quantities of extracellular fluid are 
also taken up, corresponding to 26% and 48% of the respective 
cell volumes of macrophages and fibroblasts. 
Besides fluid-phase pinocytosis, macromolecules dissolved 
in the extracellular medium can be internalized by binding to 
the cell membrane before their incorporation into the 
endocytic vesicle. This adsorptive pinocytosis may or may not 
involve a specific receptor as the membrane-binding site. 
Over two dozen examples of receptor-mediated endocytoses are 
now known (11). In general, receptor attachment does not 
induce ligand internalization but only increases the 
efficiency of uptake (a) by increasing the concentration of 
ligand at the cell surface and/or (b) by causing the 
clustering of bound ligand at sites of pinocytotic vesicle 
formation ( 5) . The adsorptive pinocytosis of 
asialoglycoproteins (12), Semiliki Forest virus (13), 
immunoglobins A and G by epithelial eels (14,15) and alpha 2-
macroglobulin-protease complexes (16) does not affect the rate 
of fluid-phase pinocytosis. However, certain polypeptide 
hormones may cause a transient increase in pinocytotic 
activity (17,18). 
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Although the intracellular pathways of molecules entering 
cells by fluid-phase, adsorptive, or receptor-mediated 
endocytosis appear similar, one possible difference is 
encountered early in the process. The binding of molecules to 
specific membrane receptors is followed very shortly by the 
concentration of the ligand-receptor complexes into 
specialized regions of the plasma membrane which are 
characterized by a cytoplasmic bristle coat ( 19) . These 
coated pits pinch off to form coated vesicles within the 
cytoplasm (20). In contrast, the pinocytosis of fluid-phase 
markers is suggested to occur via the formation of small, 
uncoated pinocytotic vesicles. 
The existence of endocytotic coated vesicles was first 
noted by Roth and Porter (21). These vesicles are transitory 
structures. Their coat structure has been studied in detail 
(13, 22) and its predominant component is a 180 kDa protein 
termed clathrin ( 2 3) . In solution, clathrin exists as a 
trimer which is called a triskelion (24, 25, 26). Under the 
appropriate conditions triskelions, along with two additional 
30 kDa proteins, will self-assemble into basket-like 
structures, even in the absence of membranes (27, 28). Other 
clathrin-associated proteins, especially a 100 kDa species, 
may help in mediating clathrin attachment to membranes (29, 
30) . 
Less is known about the membrane of coated vesicles. 
However, it is well-known that the plasma-membrane receptors 
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for a number of ligands are enriched in coated regions. More 
than 50% of some membrane-associated ligands have been 
localized in coated pits making up only two to three percent 
of the cell surface (20). Only the LDL receptor appears to be 
preferentially localized at coated pits even in the absence of 
bound ligand (22). Other receptors, for example, alpha 2-
macroglobulin and Semilike Forest virus, may accumulate at 
coated pits only after ligand binding (31). More than one 
ligand, for example, LDL and EGF, can be localized in the same 
coated pit or coated vesicle (32). 
Coated vesicles lose their coats within 15 to 60 seconds 
after their formation (12,22) and are then thought to fuse 
together to form a larger secondary endocytic vacuole, the 
endosome (12, 33). However, direct fusion with lysosomes, 
with Golgi elements, of with another domain of the plasma 
membrane may also be possible (1). 
The smooth-membrane endosomes appear to be involved in 
the concentration of internalized macromolecules and in the 
sorting of these molecules for transport to lysosomes or other 
sites. Endosomes are very heterogeneous morphologically, 
appearing as vesicles of a variety of sizes (0.1-5um diam.) as 
well as tubules, C-shaped vesicles, and multivesicular 
structures containing smaller membrane vesicles or inclusions. 
The protein-containing endosomes often appear to be 
interconnected in a complex network (34, 35, 36). 
The prelysosomal nature of endosomes has been clearly 
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established by several lines of evidence: 
1. Macromolecules enter endosomes within 30 to 60 
seconds of entry into the cell before any detectable 
degradation products are seen. 
absorbed protein do not 
Endosomes containing 
contain cytochemically 
demonstratable lysosomal enzyme activity (33, 37, 38). 
2. Incubation of many cells at temperatures of 16 to 18° 
C results in binding and internalization but not in 
degradation of the ligands even though lysosomal enzymes 
are capable of degrading the same ligands at this 
temperature. Localization of ligands in cells maintained 
at 16 to 18°C has demonstrated that they accumulate 
within the endosomes, which do not appear to be capable 
of fusing with lysosomes (39). 
3. Subcellular fractionation of cells using radioactive 
ligands to label the endosomes indicates that the 
vesicles are a distinct cellular organelle characterized 
by a lower density than other membrane fractions except 
Golgi (40, 41, 42, 43). Endosome membranes are unusual 
in having a high cholesterol content ( 44) , a feature 
which is important in the penetration of viral particles 
into the cell cytoplasm from endosomes (45). 
The polypeptide composition of endosome membrane is 
closely related to that of the plasma membrane (46, 47), and 
a 20kDa protein designation 2.6 was apparently enriched in the 
internalized compartment (48, 49). The vesicles possess a 
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very low intravesicular pH like lysosomes (50, 51). The pH of 
5.0 6.0 is maintained by a proton-translocating 
adenosinetriphosphatase which differs from that found in 
mitochondria and appears to be similar to the proton-
translocating ATPase of the plasma membrane and of the 
lysosomes (52, 53). 
The transport of 
cationized ferritin to 
plasma membrane markers 
the Golgi apparatus has 
such as 
provided 
evidence for a pathway from the cell surface to this organelle 
(12). It is important to note that in none of these systems 
is there evidence for the appearance of soluble contents of 
endosomes in Golge cisternae. Thus, the sorting of membrane 
from contents must have occurred at some earlier state, 
possible the endosome or lysosome. 
Among the possible routes taken by internalized 
macromolecules, lysosomal degradation is most frequently 
encountered and is the best-documented from the morphological, 
biochemical, and physiological points of view. In this case 
the last step of the endocytic pathway of the absorbed protein 
appears to be the fusion of endosome with primary or secondary 
lysosomes. Although complete hydrolysis to amino acids is the 
common fate of the absorbed protein in secondary lysosomes 
(54), an interesting variation of the lysosomal pathway is 
found during the sequestration of yolk protein by developing 
oocytes (55). In these cells the degradation of the 
sequestered protein is delayed until much later during 
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embryonic development. 
The endocytosis of certain proteins is not followed by 
transport to lysosomes but by release of the internalized 
molecules either at the same site that it originally entered 
the cell (3) or at another domain of the plasma membrane. An 
example of this is the transepithelial transport of 
immunoglobulin G or A (15, 56). The organelles involved in 
the cellular transit of undegraded molecules are similar to 
those comprising the lysosomal pathway. In the case of IgG 
transport, IgG-ferritin is internalized via coated pits at the 
apical surface of the epithelial cell, transported across the 
cytoplasm in uncoated endosomes, and released at the 
basolateral surface in a process involving coated pits and 
vesicles. Biochemical analysis of dimeric IgA transport 
across the hepatocyte indicates that the endocytic vesicles 
containing these ligands are similar to the organelles 
involved in the lysosomal route (57). 
Results have accumulated on the perturbation of the 
endocytic process by a variety of pharmacological agents. 
Agents perturbing the pH of endocytic structures and agents 
that affect microtubules profoundly alter the amount and the 
fate of internalized ligand (4). Steps at the cell surface as 
well as within the endosomal apparatus are sensitive to 
temperature. Internalization of ligand is markedly diminished 
by temperatures less than 5°c, and discharge from the 
endosomal compartment into secondary lysosomes is inhibited by 
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temperatures less than 20°c (14, 31). It is not clear whether 
the block by lysosomotropic agents results directly from an 
inhibition of lysosomal fusion or indirectly from an 
inhibition of the low pH-dependent discharge of the ligands 
from their receptors. 
The internalization of macromolecules within membrane-
bound vesicles requires a mechanism for replenishing plasma 
membrane surface area, since the size of the endosome and 
lysosome compartments remains constant even during prolonged 
periods of pinocytic activity (7, 10). This rapid 
replenishment of plasma membrane components does not appear to 
be achieved through increased rates of synthesis of new 
molecules but by the recycling of internalized membrane back 
to the cell surface. Membrane recycling must occur via small 
vesicle transport since their greater surface-to-volume ratio 
can recycle proportionately more membrane than content (12). 
Studies of membrane turnover are consistent with this 
conclusion. Plasma membrane proteins are degraded with half-
times much longer than the rates of membrane internalization 
during pinocytosis (58, 59, 60). This suggests that endosomes 
may be the predominant site of membrane recycling, since the 
proteins may not be exposed to lysosomes during each cycle 
(46, 47, 61, 62). Because of the low pH of endosomes and the 
ability of ligands to dissociate from their receptors at 
slightly acidic pH, it seems likely that receptor-ligand 
complexes should dissociate prior to reaching lysosomes. 
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studies of the reflux of internalized solutes such as HRP and 
sucrose indicate that the most significant amount of solute 
reflux occurs during the period immediately following 
internalization (63, 64), presumably prior to lysosomal 
fusion. 
Evidence implicating the role of endosomes in the 
recycling of plasma membrane receptors comes from the fact 
that ligands are metabolized by cells far more rapidly than 
are their receptors ( 65, 66, 67) . Whereas insulin is 
metabolized by target cells with a half-life of less than 30 
minutes, the insulin receptor has a half-life of ten hours 
( 68) . The rapid uptake of ligands by receptor-mediated 
processes along with the presence of receptors in the same 
cell fractions into which internalized ligand is concentrated 
demonstrated that ligand-receptor complexes are internalized 
by target cells (69). 
Incubation of photoaffinity-labeled EGF receptors with 
3T3 fibroblasts provided direct evidence for receptor 
internalization ( 7 0) • Comparable studies on cultured 
hepatocytes and rat adipocytes also indicated internalization 
of the photolabled receptors (71, 72). Extended incubation of 
the hepatocytes with the photolabeled EGF receptors revealed 
receptor recycling (73). 
The conclusions resulting from these studies are 
supported by a variety of other observations. Evidence for 
ligand-induced receptor internalization was demonstrated by 
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exposing cultured chick liver cells to insulin, which resulted 
in a loss of cell-surface receptors with no change in total 
receptor content ( 68) , and by the systemic injection of 
insulin, which resulted in a loss of insulin receptors from 
liver-cell plasma membranes (74) along with the correlative 
increase in receptors in hepatic Golgi fractions (75). It has 
also been shown that insulin treatment of cultured adipocytes 
reduced cell-surface receptors (76) and that EGF induced 
intracellular accumulation of its receptors in perfused liver 
(77) as well as in fibroblasts in the presence of the 
acidotropic agent methylamine (78). 
The use of antibodies to various receptors has also 
contributed to the development of a more precise picture of 
the receptors' fate. Basu et al., using an antibody to the 
LDL receptor, showed that LDL receptors accumulated in 
perinuclear vacuoles of cultured fibroblasts when these cells 
were exposed to both LDL and monensin (80). Enns et al., used 
antibodies to both transferrin and the transferrin receptor to 
show aggregation of ligand and receptor intracellularly in 
k562 human erythoid cells (80), and Geuze, Schwartz, and 
colleagues have used double-label immunoelectron microscopy to 
colocalize several ligands with their corresponding receptors 
(81, 82). 
Gueze, Schwartz also showed that the 
intracellular routes of the asialoglycoprotein and polymeric 
IGA receptors corresponded at an early stage but subsequently 
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diverged, with each entering distinctive endosomal regions 
(83). The extraordinarily high concentration of different 
receptors in Golgi saccules has indicated a role for this 
organelle not only in receptor biogenesis but also in receptor 
recycling to the cell surface. 
Such studies have shown that there are different routes 
for the handling of ligand, depending on the ease with which 
they are dissociated from their receptor. Low pH results in 
the dissociation of a large number of ligand-receptor 
complexes, including alpha 2-macroglobulin, EGF, 
asialoglycoproteins, low-density lipoproteins, insulin, and 
glycoproteins, with side chains terminating in mannose, 
mannose 6-phosphate, or N-acetylglucosamine (12}. However, 
some ligands remain bound at low pH, including IgG binding to 
intestinal epithelium Fe receptors (84), the association of 
dimeric IgA with receptors in the membrane of hepatocytes and 
mammalian-gland epithelium (85), and transferrin (86, 87). 
These exceptions are interesting, since none of these ligands 
are delivered to lysosomes, as is the case for most proteins 
exhibiting low-pH dissociation. Thus the pH dependence of the 
dissociation of the receptor-ligand complex in endosomes will 
ultimately determine the fate of the absorbed protein. 
Although the low pH of endosomes can explain many aspects 
of ligand-receptor sorting, it does not provide an explanation 
for the subsequent separation of ligand and receptor in 
different membrane compartments. Recent evidence suggests 
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that the site of separation is also the endosomes. During the 
endocytoses of asialoglycoproteins by rat hepatocytes, Geuze 
et al., (82) identified a structure called CURL (Compartment 
of Uncoupling of Receptor and Ligand), a type of endosome in 
which the asialoglycoprotein was mainly concentrated in the 
lumen and the receptor associated primarily with tubular 
extensions protruding from the main body of the vesicle. 
The uptake of different proteins by different cell types 
depends on the protein and the cell in question. Receptor-
mediated endocytosis is the most important manner by which 
epithelial cells remove proteins from the circulation (3). 
Large proteins are mostly removed by hepatocytes and cells of 
the reticuloendothelial system and have very low plasma 
turnover rates (88). Low-molecular-weight proteins and 
proteohormones are mostly removed by the proximal cells of the 
kidney and possess very high turnover rates (89). 
Renal cell uptake of low-molecular-weight proteins is a 
saturable process of high capacity and low affinity compared 
with the normal filtered load of these proteins (90). The 
kinetics of the process are probably determined by an 
interaction between the positive charges of the protein 
molecule and the negative surface charges of renal epithelial 
cells (91). Therefore, a wide variety of kinetic parameters 
of uptake, specifically Km and Vmax, is found among different 
protein species with different net charges (88). 
Morphological and kinetic studies have demonstrated that 
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derivitized cationic proteins are absorbed more avidly than 
their native anionic counterparts (89). 
The net charge of a protein also affects its uptake by 
the liver and the reticuloendothelial system. Great strides 
have been obtained in the understanding of receptor-mediated 
endocytosis, particularly of glycoproteins. Several receptor 
systems for sugar moieties of proteins have been described, 
including and N-acetylglucosamine receptor in the two-cell 
types, a fucose receptor in hepatocytes, and a mannose 6-
phosphate receptor in liver and fibroblasts {92). 
Another receptor system in which a glycoprotein is 
involved is the low-density lipoprotein system discovered by 
Brown and Goldstein (93). The LDL receptor is a glycoprotein 
with a molecular weight of 164kDa and possesses a strong 
negative charge ( 2) . The anionic groups in the receptor 
interact with cationic groups in the protein moiety apo B of 
LDL. The bound LDL is transported to the lysosomes where the 
molecule is hydrolyzed. The free cholesterol is incorporated 
into membranes of the cell or is re-esterified by acyl-CoA: 
cholesterol acyltransferase and stored in the cytoplasm. 
Cholesterol has three regulatory effects, namely repressing 
its own systhesis and that of its receptor and activating 
acyl-CoA: cholesterol acyltransferase. Thus receptor-mediated 
uptake of LDL by liver cells and fibroblasts plays an 
important role in overall cholesterol metabolism. 
The protein moiety of LDL is hydrolyzed to amino acids in 
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the lysosome, completing endocytosis (2). It was generally 
believed that endocytosed proteins like LDL were converted 
almost exclusively to TCA-soluble products in the lysosome 
(3). However, it has been shown that fibroblasts can release 
I-labeled-LDL by retroendocytosis (94, 95). In the uptake of 
ferritin by kidney cells, Mansubach et. al. (96) suggested 
that a cathepsin might be involved in lysosomal degradation. 
Cathepsins Band H have been shown to be localized mainly in 
the lysosomes of the proximal tubule cells of the rat kidney 
and that the localization of the lysosomal proteinases was 
consistent with the most active site for the absorption of the 
macromolecules (97,98,99). Recently, Yokota and Kato showed 
that cathepsins B and H are involved in the cellular 
degradation of HRP by the proximal tubule cells using 
antibodies to the proteinases and one to HRP. Thirty minutes 
after uptake of HRP, it accumulates into large aggregates 
where both enzymatic and antigenic activities appeared (100). 
The results from a further study indicated that the endocytic 
apparatus of the proximal tubule cells does not contain 
cathepsins (101). Thus the initial steps of the degradation of 
HRP in these cells seems to be carried out by proteinases 
other than cathepsins Band H whereas these cathepsins appear 
to participate in a later step. 
our laboratory has shown that mouse peritoneal 
macrophages and baby hamster kidney fibroblasts could both 
regurgitate and degrade proteins previously internalized by 
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fluid phase endocytosis ( 102) . Bovine Serum Albumin was 
allowed to incubate overnight with the MPM or BHK cells and 20 









migrated with intact BSA on Sephadex. The observed first-
order rate constants, kobs, for the 
trichloroacetic acid/phosphotungstic acid 
appearance of 
soluble- and 
trochloroacetic acid phosphotungstic acid insoluble- products 
in the culture medium were identical, indicating that the 
cells released both products in a parallel fashion. These 
rate constants were independent of the initial BSA 
concentration in the uptake medium, but were decreased about 
35% when degradation was allowed to proceed in the presence of 
a high concentration of serum. Chloroquine and Pepstatin also 
inhibited degradation, and this inhibition was accompanied by 
an increase in the total amount of regurgitated protein 
appearing in the medium. The kobs' for regurgitation was 
decreased by these inhibitors preserving the similarity in the 
observed rate constants for the appearance of TCA/PTA-soluble 
and TCA/PTA-insoluble products. These results indicated that 
a single intracellular pool of labeled substrate, whose decay 
was independent of which product was used to monitor changes 
in the size of the pool, could be the source of the TCA/PTA-
soluble products and regurgitated protein. The authors 
suggested that the transfer of extracellular proteins to 
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lysosomes may not be unidirectional, since this substrate pool 
appears to correspond to a degradative compartment. 
16 
CHAPTER II 
PURPOSE AND METHODS 
Purposes 
Previous studies in our laboratory on the degradation of 
endocytosed protein following short periods of uptake by 
cultured MPM and BHK cells found that the protein was subject 
to two competative processess, degradation and regurgitation 
(103). A kinetic analysis of the degradation and regurgitation 
progress curves (102) indicated that the same compartments 
which participate in degradation were also responsible for the 
reappearance of intact or incompletely degraded protein 
substrates in the medium. This suggests an active 
bidirectional vesicular traffic between secondary lysosomes 
and the plasma membrane. 
Two additional observations were made. First, a 
significant fraction of the labeled protein substrates 
appeared to gain access to a previously little suspected 
endocytic compartment which possessed a remarkably high 
hydrolytic capacity and in which protein resided for only a 
short time. The half life this compartment was about 5 to 10 
minutes which is similiar to that observed for pinocytic 
vesicles. However, pinosomes have not previously been reported 
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to possess significant proteolytic activity. Secondly, with 
cytochrome c and enolase as substrates, high performance gel 
permeation chromatography of the material released by the 
cells indicated that the TCA precipitable radioactivity had a 
higher apparent molecular weight than the starting substrate. 
Therefore, these internalized proteins appeared to have 
undergone some physical or chemical modification prior to 
their degradation. 
The purpose of this study is as follows: 
1. To determine whether a precursor-product relationship 
exists between the various intracellular pools of endocytosed 
protein; 
2. To determine the nature of the physical or chemical 
changes which occur in protein substrates prior to their 
degradation to low molecular weight products. 
Methods 
Synthesis of I-labeled Protein Substrates 
Horse heart cytochrome c and rabbit muscle enolase were 
iodinated using [ 1251] NaI (Amersham-Searle) and a Bio-Rad 
Enzymobead kit (Bio-Rad Laboratories) according to the 
instructions of the manufacturer. Unreacted label was removed 
by ion exchange chromatography on a 1 by 1 cm. column of Dowex 
1-X8 as described by Osheroff et al., (104). The labeled 
proteins were either kept at 4°C and used immediately or were 
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frozen and stored at -20°c for later use. Diiodotyrosine and 
monoiodotyrosine were labeled according to the method of 
Savoie et al, (105) using Chloramine T and [ 125 rJ NaI. 
Cell Culture 
Normal human fibroblasts, GM3440, low passage number were 
obtained from the NIGMS Human Genetic Mutant Cell Repository, 
Institute for Medical Research, Camden, NJ. Cells were grown 
in either 75 cm. tissue culture flasks (Falcon) or 60 by 15 
mm. tissue culture dishes (Falcon) in Delbecco modified 
Eagle's medium supplemented with 13% fetal bovine serum, 0.lM 
glutamine, mycoplasma and bovine adventitious agents negative 
(Flow Laboratories), and 1.7% penicillin-streptomycin (GIBCO 
Laboratories). This mixture will be referred to as medium in 
subsequent discussions. Cells were grown to confluency as 
judged by microscopic examination and each small plate had an 
average of 186,000 cells. 
Uptake and Degradation of Radiolabeled Proteins by Fibroblasts 
Human fibroblasts, grown to apparent confluency, were 
incubated with from 1 uci to 10 uci of I-labeled protein in 1 
ml of medium. At the end of the uptake period the cellular 
monolayer was rapidly washed four times with phosphate-
buffered saline, and 1 ml of unlabeled medium was added to the 
60 by 15 mm tissue culture dish. During the first hour, all 
the medium was removed and replaced with fresh media at five-
19 
minute intervals. During the second hour, the media was 
collected at intervals of 30 min and thereafter at intervals 
of one to two hours as the incubation period progressed. Each 
sample of medium was treated with 1 ml of 20%TCA - 1%PTA, 
stored on ice for 30 minutes and them cenrifuged at 4°C for 
ten minutes. The TCA-PTA soluble and insoluble 
radioactivities were then measured separately in a TM 
analytical model 191 gamma counter. After removal of the last 
sample of medium for processing, the cell monolayer was 
extracted with 2 ml. of 0.6% SDS containing 0.01 EDTA (106). 
After incubation for five minutes at room temperature the 
viscous extract was removed for measurement of radioactivity. 
Calculation of Progress Curves and Rate Constants 
Progress curves for the release of TCA-PTA soluble and 
TCA-PTA insoluble radioactivities were analyzed separately. 
The release of both products were monitored for 70% to 90% of 
the reactions. Because it was not feasible to follow the 
reactions to completion, it was necessary to apportion the 
label remaining in the monolayer at the end of the expermiment 
between the two products. This was done by calculating R3 , 
the ratio of the rates of TCA-PTA soluble to total 
radiactivity released during the intervals of the late 
incubation times. The amount of radioactivity remaining in 
the monolayer at the end of the experiment which might give 
rise to TCA-PTA soluble products is then R3 X CP~onolayer. 
Therefore, at each time point the fraction of the cellular 
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radioactivity remaining in the monolayer which could give rise 
to soluble products is given by: 
( l) ( F sol) t = l - { ( CPMsol) t / [ R3 X CPMmonolayer + ( CPMsol) e] } 
where (CPMs01 ) e is the total amount of TCA-PTA soluble released 
from the monolayer by the end of the experiment and (CPMsol)t 
is the total amount of TCA-PTA soluble radioactivity released 
by time t. For TCA-PTA insoluble radioactivity we can also 
write: 
( 2 ) (Finsol)t = l- {(CPMinsol)t /[(l-R) X (CP~onolayer + 
CPMinsol) e] } 
For a first-order process in which a single substrate pool 
gives rise to both products, or a given product arises from a 
single unique pool, then plots of the natural log of (Fsol)t 
and (Finsol)t vs. time is expected to yield straight lines with 
slopes equal to the rate constant for the depletion of the 
corresponding substrate pool. In contrast, I observed that 
plots of the natural log of either (Fsol)t of (Finsol)t vs. 
time were curvilinear for cytochrome c. The time course for 
the release of label from the cell monolayer could be 
described as a sum of three exponential terms according to 
equations 3 and 4: 
(3) 
(4) 
( F ) = Ae-kaobs + Be-kbobs + ce-kcobs sol t 
(F, ) = A'e-ka' obs + B'e-kb' obs + C'e-kc' obs 1.nsol t 
The various parameters in these equations were estimated 
independently from the data for TCA-PTA soluble and insoluble 
radioactivity by nonlinear regression analysis with the 
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program Enzfit. Generally, it was observed that the rate 
constants for each phase of the reaction were similar or 
identical for the two products (TCA-PTA soluble and insoluble 
radioactivity released), indicating that both products arose 
from common substrate pools. Accordingly, the averaged values 
of the rate constants were used in further calculations of 
pool sizes and intrinsic degradation and regurgitation rate 
constants. 
Calculation of the Size of the Individual Substrate Pools & 
Degradation & Regurgitation Rate Constants 
The fraction of the total cellular protein which 
participates in a given phase of degradation and regurgitation 
and the intrinsic degradation and 
regurgitation (ka)reg rate constants which characterize that 
phase can be calculated from the original data. The equations 
used to calculate these parameters can be demonstrated for 
the first phase (phase A} as follows: 
Pa/ (P)tot =AR+ A' (1-R} 
(ka)deg / (ka)obs = AR/ [AR+ A'(l-R}J 
(ka)reg / (ka)obs = A' (1-R} / [AR+ A' (1-R}] 
In these equations, (ka)obs, A and A' are known from 
evaluation of equations 3 and 4 as described. R is the ratio 
of total TCA-soluble radioactivity to total protein released 
were the reaction to go to completion. 
with the following equation: 
R = [ R3 X CPMroonolayer) + ( CPMso1l.,_,_ ___ _ 
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R can be estimated 
CPMuionolayer + (CPMsol>e + (CPMinsol>e 
The various terms in the above equation have been previously 
defined. The proportion of labeled proteins corresponding to 
pools Band C, and the intrinsic degradation and regurgitation 
rate constants for phases Band C were calculated in a similar 
manner. 
Analysis of Labeled Material Released by Cultured Fibroblasts 
1. Ultracentrifugation 
Following the uptake of iodinated cytochrome c for a 
period of one hour the monolayer was washed as previously 
described. At 0.5hr. and 5hrs. an aliquot of the release 
medium was centrifuged at 100,000g for ten minutes (107) and 
the radioactivity in the resulting pellet and supernatant 
counted. After 5hr a second sample of the release medium was 
removed; the cells were then washed with PBS and collected by 
scraping the dish with a rubber policeman. The cells were 
subsequently homogenized by a Polytron ultrasonic homogenizer, 
subjected to ultracentrifugation as described, and the 
supernatant and pellet counted for radioactivity. 
2. Gel Exclusion Chromatography 
Samples of the release medium obtained at 0.5hrs and 5hrs 
were filtered through a 0.45um Millipore membrane and 500ul of 
the filtered medium was applied to a calibrated Toyo Soda 
G3000 SW high-performance gel filtration column previously 
equilibrated with 5rnM sodium phosphate buffer, pH 6.8, 
containing O.lM NaCl. The proteins used to calibrate the 
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column were catalase (Mw. 250,000), phosphorylase B(Mw. 
184,800}, alcohol dehydrogenase (Mw. 150,000}, enolase (Mw. 
67,000), ovalbumin (Mw. 45,000), hemoglobin (Mw/ 16,760), 
cytochrome c(Mw. 12,384}, and the B-chain of insulin. The 
column effluent was monitored with a Waters model 440 U.V. 
detector at both 210 and 280 nm. When samples contained I-
labeled proteins, the effluent from the detector was connected 
to a Gilson microfractionater and the fractions counted as 
described previously. 
3. SDS Polacrylamide Slab Gel Electrophoresis 
After iodination of the protein substrate, it was 
subjected to SOS-PAGE using a Bio-Rad Protean electrophoresis 
apparatus according to the method of Weber and Osborn (108). 
Each lane was divided into 2mm. sections and their 
radioactivity measured. 
4. Analysis of Low Molecular Weight Products 
Monoiodotyrosine, diiodotyrosine, and free iodine were 
separated by chromatography on a column of Bio-Gel P2 
according to the method of Thomopoulos (109). Samples (0.4ml) 
of release media were applied to a 39cm X 0.9cm column of Bio-
Gel P2. Fractions were collected and counted as described 
previously. In order to verify that the column could 
effectively separate mono- and diiodotyrosine and free iodine, 
the corresponding radiolabeled standards prepared as described 
above were chromatographed separately. (125I)NaI, 
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monoiodotyrosine and diiodotyrosine reproducibly appeared at 




Figures 1,2,3 and 4 show the time course for the release 
of TCA/PTA-soluble and -insoluble radioactivity from cultured 
fibroblasts following a 30-minute and 5-hour incubation period 
with 125I-cytochrome c. Logarithmic plots of the experimental 
points (not shown) do not fall on a straight line, indicating 
that product release is multiphasic. Using the Enzfit 
nonlinear regression analysis program, 
resolve these curves into three phases. 
Figures 1, 2, 3 and 4 were calculated by 
it was possible to 
The solid lines in 
assuming that the 
release of TCA-PTA soluble and insoluble radioactivity from 
the fibroblast monolayer can be described as the sum of three 
exponential decay curves. The various parameters in these 
equations are displayed in Tables I and II for various periods 
of uptake from 5 minutes to 24 hours. These results reveal 
that the observed rate constants for the release of TCA-PTA 
soluble (kobs) and TCA-PTA insoluble (k'obs) radioactivity are 
generally similar for each of the three different phases of 
the decay curves. This suggests that the TCA-PTA soluble and 
insoluble radioactivity arise from parallel reactions acting 









Fig 1 . 
0 400 800 1 200 1 600 2000 
Time (min) 
Release of TCA-PTA soluble radioactivity into the medium 
after a 30min uptake of [ 125 l]-cytochrome c. The 
amount of radioactivity in the medium was calculated 
according to Methods and the closed circles ( • ) 
represent values determined experimentally. The straight 
line (--) represent values that ere calculated according 










0 400 800 1 200 1 600 2000 
Time (min) 
Release of TCA-PTA insoluble radioactivity into the medium 
after a 30min uptake of [ 125 l]-cytochrome C. The amount 
of radioactivity was calculated according to Methods 
and the closed circles ( e ) represent values determined 
experimentally. The straight (--) line represents values 









0 400 800 1200 1 600 2000 
Time (min) 
Fig 3. 
Release of TCA-PTA soluble radioactivity into the medium 
125 
after a 5 hour uptake of [ l]-cytochrome c. The amount 
of radioactivity in the medium was calculated according to 
Methods and the open circles ( Q ) represent values 
determined experimentally. The straight line (--) 
represents values that were calculated according to the 
program Enzfit. 
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0 400 800 1 200 1 600 2000 
Time (min) 
Release of TCA-PTA insoluble radioactivity into the 
medium after a 5 hour uptake of [ 
125
I]-cytochrome c. 
The amount of radioactivity in the medium was 
calculated according to Methods and the open circles 
( Q ) represent values determined experimentally. 
The straight line (--) represents values that were 
calculated according to the program Enzfit. 
30 
Table 1. 
Effect of Uptake Period on the Rates and Extents of the 
Three Phases of Appearance of TCA-Soluble Products 












= 5 minutes 
kobs (min-1) 
0.0522 ± 0.0024 
0.0053 ± 0.0004 
0.0002 + 0.00001 
= 30 minutes 
kobs (min-1) 
0.0732 ± 0.0053 
0.0083 ± 0.0008 
0.0010 + 0.0001 
= 1 hour 
kobs (min-1) 
0.2185 ± 0.0200 
0.0143 + 0.0008 
0.0016 + 0.0001 
Duration of uptake= 1 hour, Uptake carried 
presence of a 1000 fold excess of unlabeled 
kobs (min-1) 
0.0547 ± 0.0370 
0.0082 + 0.0020 












= 5 hours 
kobs (min-
1) 
0.1245 + 0.0790 
0.0060 + 0.0013 
0.0011 + 0.0001 
= 24 hours 
kobs (min-1) 
0.0287 + 0.0037 
0.0059 + 0.0016 
0.0010 + 0.0002 
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Extent 
0.256 + 0.006 
0.198 + 0.005 
0.510 + 0.006 
Extent 
0.342 + 0.012 
0.318 + 0.012 
0.342 + 0.014 
Extent 
0.359 + 0.031 
0.262 + 0.006 
0.143 + 0.007 
out in the 
cytochrome c 
Extent 
0.083 + 0.028 
0.250 + 0.023 
0.659 + 0.014 
Extent 
0.090 + 0.038 
0.285 + 0.043 
0.649 + 0.049 
Extent 
0.389 + 0.051 
0.318 + 0.041 
0.254 + 0.044 
Table 2. 
Effect of Uptake Period on Rates and Extents of the 
Three Phases of Appearance of TCA -Insoluble Products 












= 5 minutes 
kobs (min-
1) 
0.0483 ± 0.0019 
0.0055 + 0.0005 
0.0002 + 0.00002 
= 30 minutes 
kobs (min-1) 
0.1024 ± 0.0078 
0.0105 ± 0.0008 
0.0011 + 0.00006 
= 1 hour 
kobs (min-1) 
0.2398 ± 0.0566 
0.0410 ± 0.0042 
0.0032 + 0.0002 
Duration of uptake= 1 hour, Uptake carried 
presence of a 1000 fold excess of unlabeled 
kobs (min-1) 
0.0294 ± 0.0047 
0.0039 + 0.0022 












= 5 hours 
kobs (min-1) 
0.0992 ± 0.007 
0.0080 + 0.0006 
0.0012 + 0.00008 
= 24 hours 
kobs (min-1) 
0.0332 ± 0.0046 
0.0044 + 0.002 
0.0009 + 0.0004 
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Extent 
0.414 + 0.008 
0.225 + 0.007 
0.331 + 0.008 
Extent 
0.393 + 0.014 
0.336 + 0.011 
0.290 + 0.012 
Extent 
0.504 + 0.074 
0.436 + 0.038 
0.220 + 0.010 
out in the 
cytochrome c 
Extent 
0.500 + 0.060 
0.291 + 0.052 
0.208 + 0.084 
Extent 
0.354 + 0.013 
0.355 + 0.015 
0.326 + 0.018 
Extent 
0.534 + 0.050 
0.308 + 0.058 
0.145 + 0.068 
the same rate constants are expected irrespective of which 
product is measured to monitor the rate of decay of a 
particular substrate pool. 
The results that I obtained for cytochrome c in Figures 
1,2,3, and 4 and presented in Tables I and II support the 
conclusion that each phase of release of label corresponds to 
a first-order decay of a specific substrate pool which is 
depleted by the simultaneous occurrence of degradation and 
regurgitation. Thus, the observed rate constants, kobs and 
k'obs corresponding to a given phase of release, are identical 
to each other and equal to the sum of the intrinsic 
degradation and regurgitation rate constants kcteg and kreg for 
that phase. For phase A: kobs = k'obs = kdeg + kreg• 
The fraction of the total cellular protein which 
participates in a given phase of degradation and regurgitation 
and the intrinsic degradation and regurgitation rate constants 
which characterize that phase can be calculated from the 
original data after being treated as described in Methods. 
This second set of parameters can be found in Table III and 
the equations used to calculate them can be demonstrated for 
the first phase (phase A) as the following example 
illustrates: 
Pa/ ptotal = AR + A' (1-R) 
(ka>ctegf (ka)obs = AR/ [AR+ A'(l-R)] 
(ka>regf (ka)obs = A'(l-R)/ [AR+ A'(l-R)] 
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Table 3. 
Effects of Uptake Period on the Degradation and 
Re~urgitation Rate Constants and the Relative Pool Sizes for 





















Duration of uptake = 5 minutes 
Fractional Pool Size Rate Constants (min-1 ) 
(Pf Ptotal) kde~ kre[j 
0.303 0.0 97 0. 205 
0.206 0.0036 0.0018 
0.457 0.0001 0.00004 
Duration of uptake = 30 minutes 
Fractional Pool Size Rate Constants (min-1 ) 
(P/Ptotal) kde~ kre6 
0.350 0.0 28 0. 15 
0.321 0.0079 0.0015 
0.334 0.0009 0.0001 
Duration of uptake = 1 hour 
Fractional Pool Size Rate Constants (min-1 ) 
(Pf Ptotal) kde1 kre6 
0.398 0.0 51 0. 078 
0.309 0.0171 0.0105 
0.164 0.0020 0.0004 
of uptake= 1 hour, Uptake carried out in the 
of a 1000 fold excess of unlabeled cytochrome c. 





Duration of uptake= 
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In these equations, ( k ) A and A' are known from a obs' 
evaluations of equations 3 and 4 as described in Methods. R 
is the ratio of total TCA soluble radioactivity to total 
protein released were the reaction to go to completion. R can 
be estimated with the following equation: 
R = B3 X CPMmonolayer + (CPMsol)e 
CPMmonolayer + (CPMsol)e + (CPMinsol)e 
The various terms in the above equation are defined in 
Methods. The proportion of labeled proteins corresponding to 
pools Band C, and the intrinsic degradation and regurgitation 
rate constants for phases Band C appearing in Table III were 
calculated in a similar manner. 
These results indicate that the compartment responsible 
for the initial rapid phase (phase A) contributes 30%, 35%, 
and 40% to the total TCA-PTA soluble radioactivity released 
after a 5min, 3 Omin, and one-hour uptake of [ 1251 J -labeled 
cytochrome c by endocytoses. It can be seen that after a 5-hr 
uptake period, compartment A contributes only 15% of the total 
amount of labeled products released while the slower phases 
contain most of the protein. However, by 24-hr phase A 
increased again to 45%. As the time required for a pinocytic 
compartment to fill to its steady state level is directly 
related to the time required for the same compartment to 
empty, it is expected that compartment A will become filled 
prior to compartments B and C. Accordingly, compartment A 
should make a progressively smaller contribution to the total 
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substrate present within th~ cell as the duration of the 
uptake period increases; eg. PA/PT decreases as t increases. 
From the results in Table Ill, this does not appear to have 
been the case. Consequently, my data do not support a model in 
which the individual cellular compartments, corresponding to 
phases A,B, and c, become filled sequentially or in parallel. 
In order to determine whether non specific binding to 
the culture dish or to the cell surface might have contributed 
to the multiphasic appearance of products, a second experiment 
was performed with a 1000 fold excess of unlabeled cytochrome 
c was present in the 1hr uptake medium added along with the 
labeled cytochrome c during the 1 hour uptake period. A 
comparison of the observed rate constants for the release of 
TCA/PTA-soluble and -insoluble radioactivities with those 
observed in the absence of excess cytochrome c reveal an 
effect of excess cytochrome con cytochrome c degradation. 
Although phase C appears more extensive, phases A and B were 
not eliminated by the presenc~ of excess unlabeled cytochrome 
c during [ 125IJ-labeled cytochrome c uptake. Thus all three 
substrate pools makes significant contributions to both the 
degradation and regurgitation of TCA/PTA -soluble and -
insoluble radioactivity unde:t' conditions where nonspecific 
binding of the labeled substrate is not favored. 
A series of experiments ~ere then performed to determine 
the nature of the TCA-PTA-insoluble radioactivity released by 
cultured fibroblasts. In one experiment the cells were 
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incubated with [ 125IJ-labeled cytochrome c and the release 
medium subjected to ultracentrifugation as described in 
Methods. The results as seen in Table IV indicate that very 
little of the label released by fibroblasts can be sedimented 
at high speeds; it is therefore not associated with vesicles 
or particulate structures. 
In a second experiment [ 1251 ]-cytochrome c and [ 1251 ]-
enolase were prepared and both proteins subjected to slab gel 
electrophoresis. The proteins were pure species as seen in 
Figure's 5 and 6. Fibroblasts were then permitted to take up 
[ 125rJ-enolase for one hour; the cells were washed as before 
and supplemented with fresh medium. After 0.5hr the medium was 
removed, filtered and an aliquot analyzed by high-performance 
gel permeation chromotography. Figure 7 shows the pure 
protein eluting at 26 minutes and Figure 8 shows the presence 
of multiple iodinated species in the release medium including 
a number of radioactive species that are larger {23 min and 19 
min) and smaller (31 min and 45 min) than native enolase. 
This indicates that after uptake by fibroblasts, enolase can 
be regurgited into the medium and it can be processed to 
larger and smaller products which are also released. 
This same experiment was also performed with labeled 
cytochrome c. The HPLC column was calibrated with the protein 
standards listed in Methods and the profile with [ 125rJ-
cytochrome c is shown in Figure 9. Fractions 38-42 contain 









Ultracentrifugation of Medium and Cell Lysate 
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HPLC chromatogram of iodinated enolase on 
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HPLC chromatogram of 30 minute media sample 
after incubation of fibroblasts with iodinated 
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HPLC chromatogram of iodinated cytochrome c 
on the Toya Soda column. 
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Fig. 1 1 
0 10 20 30 40 50 60 70 
Fraction Number 
HPLC chromatography of media samples and 
cell lysate. Cells were incubated with [
125 !]-
cytochrome c and the media removed at 30 
minutes (------) and again at 5 hours (···········) 
according to Methods. After the cells had been 
washed, they were lysed and an a Ii quot (--) 
injected onto the Toya Soda column according 
to Methods. 
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Figure 11 contains the profile of the release medium after 0.5 
and 5.0 hours as well as a 500ul aliquot of the cell lysate at 
the end of the experiment. 
Of the different iodinated species present in the medium 
and the cell lysate, one can find intact [ 1251)-cytochrome c 
at fraction 35 and [ 1251)-monoiodotyrosine at fractions 38-42. 
Additional peaks of higher molecular weight can also be found 
at fractions 17, 25, and 31. At 30 min., the amount of 
labeled products released which appear to be larger than 
monoiodotyrosine (fractions 17-38) is much greater than the 
monoiodotyrosine peak at fraction 38-42. However, the 
chromatogram obtained with the release medium after five hours 
shows that monoiodotyrosine is the dominant peak. The cell 
lysate obtained after five hours shows a preponderance of high 
molecular weight radioactive species. 
The molecular weights of the protein species found at 
peaks 17, 25, and 31 present in all three chromatograms 
estimated from calibration curves of elution volumes versus 
molecular weight obtained with the HPLC column are greater 
than 235,00 for the first, 89,000 for the second and 15,800 
for the third. In addition to the presence of a peak 
corresponding to cytochrome c, the fibroblasts also released 
lower molecular weight species into the media sampled at 30 
minutes, as was seen with enolase. 
The small molecular weight material seen in the HPLC 
chromatograms was further analyzed by chromatography on a 
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column of Biogel P-2 as described in Methods. The column was 
standardized with Na[ 125IJ, which has a peak at fraction 28 as 
seen in Figure 12. Figure 13 shows a mixture of [ 125 1 J -
cytochrome c and [ 125rJ-labeled mono and diiodotyrosine. 
[ 125IJ-cytochrome c eluted at fraction 11, and [ 125IJ-
monoiodotyrosine eluted at fraction 41-44. The identity of 
the peak at fraction 53 is not known while [ 125r] -diiodo-
tyrosine eluted at fraction 75. 
Figure 14 are elution profiles obtained for filtered 
aliquots of the 30-minute release medium, the 5-hour release 
medium and a cell lysate prepared by sonication of the cells 
at the end of the experiment. All three chromatograms reveal 
the presence of [ 125IJ-labeled species which are excluded by 
the gel and eluate in the void volume of the column at 
fraction 12. These would correspond to labeled protein. From 
the peaks corresponding to fractions 40-43, it is evident that 
a larger amount of [ 125IJ-monoiodotyrosine is present in the 
5-hour media sample than in the 30-minute media sample or in 
the cell lysate. In addition, the fibroblast lysate appears to 
contain intermediate molecular weight species which eluates at 
between fractions 14 and 40. Presumbly these correspond to 
incompletely degraded products. 
The relative amounts of radioactivity which eluted in the 
void volume of the Biogel P-2 column was much less than 
expected based on the amount of label recovered in the high 












Fig. 1 2 
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Fig. 1 3 
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Chromatography of [ 
125
I]-cytochrome c, [ 125 I]-MIT, 
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0 1 0 20 30 40 50 60 70 80 90 
Fraction Number 
Chromatography of media samples and cell lysate. Cells 
were incubated with iodinated cytochrome c and the media 
was removed at 30 minutes (-·· .. ···) and again at 5 hours 
(·--- ). A 400ul aliquot of the cell media as well as the 
cell lysate (--) was applied to the Bio-Gel P2 column. 
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the Toya Soda HPLC column. Media samples were therefore 
chromatographed on the Biogel P-2 column in the presence of 
O. lM sodium chloride in order to eliminate possible ionic 
interactions between the highly charged cytochrome c and the 
Biogel P-2 resin. The fraction of the total radioactivity 
recovered in the void volume from the Biogel P-2 column was 
now similar to that observed by high-performance gel exclusion 
chromatography on the Toya Soda column (data not shown). These 
results clearly indicate that fibroblasts release in addition 
to monoiodotyrosine a number of high molecular weight products 




The release of trichloroacetic acid - precipitable 
material following the fluid phase endocytosis of horseradish 
peroxidase by Chinese hamster ovary cells (65) and the 
receptor mediated endocytosis of low density lipoprotein by 
fibroblasts (97) suggests that regurgitation or exocytosis of 
internalized substrates may be a general phenomenon in 
mammalian cells. It had been suggested that the regurgitated 
proteins are derived from an endosomal compartment as a 
consequence of the recycling of endosomal membrane by small 
vesicles containing an entrapped aqueous space (10). In this 
work I have consistently observed that following the uptake of 
[ 125rJ- cytochrome c by cultured human skin 
fibroblasts,labeled products are released in a manner 
consistent with the existence of three kineticaly distinct 
pools of labeled substrates. All three pools contribute to the 
appearance of both trichloroacetic acid-soluble and -insoluble 
products irrespective of the uptake period from 5 minutes to 
24 hours. For each of the three phases of release of products, 
the half-lives for the appearance of TCA/PTA soluble and 
TCA/PTA-precipitable materials are similiar (Tables I and II) 
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suggesting that both types of products arose from the same 
substrate pools. 
An analyses of the products released by fibroblasts which 









molecular weight fragments. The intermediate and low molecular 
weight fragments could be subdivided into proteinacious 
substances and monoiodotyrosine by chromatography on the 
Biogel P-2 column. These results suggest that all three 
cellular compartments which give rise to labeled products can 
participate in both substrate degradation and regurgitation. 
Accordingly, my results suggest that every kinetically 
distinguishable compartment on the endocytic pathway may be 
capable of degrading protein substrates to TCA/PTA -soluble 
products and of regurgitating intact and incompletely degraded 
substrates as TCA/PTA -precipitable products. 
Evidence for the involvement of endosomes in endocytosis 
has been accumulating. The half-life of this rapid 
retroendocytosis is about 5-10 minutes and is mostly complete 
by 60 minutes (110,111,65,112). In this thesis I am suggesting 
that the rapid phase of release of TCA-precipitable 
radioactivity following uptake of [ 125IJ-cytochrome c is 
similiarly due to endosomes. The high hydrolytic activity (8-
39% of the total radioactivity incorporated into the 
fibroblasts) of this rapid regurgitative compartment could be 
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due to active cathepsin D which was demonstrated by Diment and 
Stahl (113) in early endosomes. The rapid degradative 
compartment in addition to contributing 8 to 3 9 % of the 
TCA/PTA-soluble radioactivity released by the fibroblasts was 
also responsible for the appearance of 35% to 53% of the 
TCA/PTA insoluble material regurgitated by fibroblasts. The 
rapid return of endocytosed material to the medium has been 
seen in cultured basement membrane endothelial cells where 70% 
of Lucifer Yellow was found to be released into the medium at 
4°c of uptake (114). It has been shown that the amount of cell 
associated pinocytosed material has a curvilinear dependence 
on the time of labeling and the kinetics of the loss of 
material are consistent with their regurgitation from 
endosomes (64,65,115,98). 
In addition to the loss of pinocytosed material to the 
media, the endocytosed protein can be delivered to the 
lysosomes where it was once thought to be degraded completely 
to monoiodotyrosine. The consistent regurgitation of intact 
cytochrome c to the media during the slower phases of release 
of products leads to the conclusion that regurgitated 
materials can also arise from lysosomes. This is similiar to 
conclusions based on earlier studies in this laboratory with 
mouse peritoneal macrophages (103). The slow phase of release 
of TCA/PTA-soluble and insoluble products appeared to be due 
to two kinetically distinguishable substrate pools,B and C. If 
pool B corresponds to lysosomes,then the third phase, pool C 
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may be due to residual bodies which are known to be the 
terminal compartments of endocytosis (116). 
and 
The simpliest model which can 
which is consistent with 
described for my results, 
the results of others 
(10,12,14,31,33,39,54) is a sequential one in which substrates 
are transferred from compartment A to B to c, corresponding to 
endosomes, lysosomes and residual bodies, with each 
compartment being able to both degrade and regurgitate the 
substrate (Model 1, Fig. 15). A second model which is also 
consistent with the kinetic results obtained for cytochrome c, 
but which is not strongly supported by other results, might be 
considered a parallel model (Model 2, Fig. 15). In this model, 
endocytosed proteins are distributed between three 
prelysosomal compartments which can either regurgitate the 
substrate or transfer it to the lysosome. If degradation in 
the lysosome is very rapid so as not to be rate limiting, then 
the three phases for the appearance of TCA/PTA -soluble and -
insoluble products is also expected. Furthermore, identical 
rate constants are expected for a given phase of release of 
acid soluble and acid insoluble material. 
The two models predict different meanings for the observed 
rate constants. For model 1, the rate constant describing the 
disappearance of each phase is the sum of the corresponding 
degradation, regurgitation and transfer rate constants; 
kobs = kd + kr + kt· (The exception is phase C for which 
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Fig. 15 krC 
In model 1 protein is both regurgitated and degraded by three compartments and the TCA-PTA soluble and 
insoluble radioactivity arise from pool A at first. After transfer of protein from compartment A to 
compartment B, TCA- PTA soluble and insoluble radioactivity are released into the medium from this 
second pool. Finally, there occurs a sequential transfer of labeled material from compartment B to 
compartment C and the release of TCA-PTA soluble and insoluble radioactivity. Thus, after the endo-
cytosis of protein by the cell, the protein is sent from one compartment to the next in a definite order. 
However, in model 2 the regurgitation of protein from the three distinct compartments occurs simul-
taneously. All three pools transfer their contents to the lysosomes at the same time resulting in a 
singular release of TCA-PTA soluble products into the medium. 
disappearance of each phase is the sum of the corresponding 
transfer and regurgitation rate constants; kobs = kt + kr. 
Model 2 predicts that the observed rate constants should not 
vary with the nature of the protein substrate as kt and kr are 
expected to be independent of the identity or physical state 
of the protein. In constrast, model 1 predicts that kobs 
should be dependent on the intrinsic susceptibility of the 
substrate toward proteolysis (ka)· The finding in an earlier 
study that kobs varies with the identity and physical state of 
the substrate {118) argues against model 2, or one like it. 
Both models 1 and 2 predict that compartment A should 
make a decreasing contribution to the appearance of TCA/PTA-
soluble and -insoluble products as the duration of the period 
of substrate uptake is increased. This is because the time 
required for a compartment to fill to capacity is identical to 
the time required for it to empty. Thus compartment A should 
reach its full capacity by 60 minutes (8 half-lives) given an 
average value of kobs for emptying of 0.092min-1 • Compartments 
Band C should continue to fill after 60 minutes; compartment 
B (kobs = 0.0l0min-1 ) should reach its capacity by 9.1 hrs (8 
half-lives) and compartment C (kobs = 0. 00102) should be 
filled to its maximum by 91 hrs or 3.8 days (8 half-lives). 
Thus, for uptake periods which exceed 1hr, phase A should make 
a decreasing contribution to the appearance of products as 
compartments Band C continue to fill. Although the results 
for the uptake periods of 1 and 5hrs agree with this 
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expectation, the results for the 24hr uptake period are 
discordent (Table 3). Thus, compartment C contributes 50% of 
the total products released after 5hrs of uptake but this 
decreases to 21% after 24hrs of uptake. 
There are several possible explanations for my failure to 
observe the expected trend in the ratio of PA/Ptotal with 
changes in the duration of the period of substrate 
accumulation in the cells. One explanation may be the 
difficulty of exactly replicating the conditions of each 
experiment. Thus, a difference of 7 to 8 minutes between 
experiments in the time employed to wash the monolayer after 
substrate uptake, but before the begining of measurements of 
product release can produce variations in the ratio PA/Ptotal 
of upto 2 fold. Second, nonspecific binding of the protein 
substrate to the cell surface, with subsequent release at 
latter times, might alter the relative sizes of the three 
substrate pools. In agreement, increasing the concentration of 
cold cytochrome c 1000 fold during uptake to compete with 
labeled cytochrome c for binding, increased the magnitude of 
the slow phase of product release (phase C) by a factor of 3. 
A second observation of interest is my finding that some 
labeled products regurgitated into the culture medium are 
larger than the native substrate. It is likely that this is 
due to the formation of protein aggregates which are 
stabilized by interchain disulfide bonds. Protein aggregation 
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is frequently observed to proceed proteolysis in intracellular 
protein degradation. 
In conclusion, human skin fibroblasts appear to contain 
three kinetically distinct intracellular compartments which 
participate in the degradation and regurgitation of the 
endocytosed protein substrates. The half-life of the rapid 
compartment is similiar to that of endosomes, suggesting that 
endosomes has a substantial ability to degrade protein. In 
addition, protein aggregation appears to be associated with 
the degradation of endocytosed proteins and is reflected in 
the regurgitation of protein products which are larger than 
the initial substrate. 
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